Filing Details

Accession Number:
0000950170-24-075723
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-06-20 17:01:13
Reporting Period:
2024-06-18
Accepted Time:
2024-06-20 17:01:13
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1787400 Nkarta Inc. NKTX Pharmaceutical Preparations (2834) 474515206
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1853197 Ralph Brandenberger C/O Nkarta, Inc.
1150 Veterans Boulevard
South San Francisco CA 94080
Chief Technical Officer No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2024-06-18 229 $5.60 79,743 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. Represents shares sold as required by the applicable award terms to satisfy tax withholding obligations in connection with the vesting and settlement of Restricted Stock Units and does not represent a discretionary transaction by the Reporting Person.
  2. This transaction was executed in multiple trades at prices ranging from $5.58 to $5.60. The price reported above reflects the weighted average price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.